The Prostacyclin Analogue Beraprost Sodium Prevents Occlusion of Bypass Grafts in Patients with Lower Extremity Arterial Occlusive Disease: A 20-Year Retrospective Study
- 1 November 2005
- journal article
- Published by Elsevier BV in Annals of Vascular Surgery
- Vol. 19 (6), 838-842
- https://doi.org/10.1007/s10016-005-7668-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Saphenous Vein Versus PTFE for Above-Knee Femoropopliteal Bypass. A Review of the LiteratureEuropean Journal of Vascular and Endovascular Surgery, 2004
- Long-term Outcome of Femoral Above-knee Popliteal Artery Bypass Using Autologous Saphenous Vein Versus Expanded Polytetrafluoroethylene GraftsAnnals of Vascular Surgery, 2003
- Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2analogueJournal of the American College of Cardiology, 2003
- Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin I2 analogueJournal of Endocrinology, 2002
- Fluid Dynamics, Wall Mechanics, and Oxygen Transfer in Peripheral Bypass AnastomosesAnnals of Biomedical Engineering, 2002
- Oral Beraprost Sodium, a Prostaglandin I 2 Analogue, for Intermittent ClaudicationCirculation, 2000
- Prosthetic above-knee femoropopliteal bypass grafting: Results of a multicenter randomized prospective trialJournal of Vascular Surgery, 1997
- Second European Consensus Document on Chronic Critical Limb IchaemiaEuropean Journal of Vascular Surgery, 1993
- Long-term results of infrainguinal revascularization with polytetrafluoroethylene: A ten-year experienceJournal of Vascular Surgery, 1992
- Alteration in prostacyclin and prostaglandin E2 production. Correlation with changes in human aortic atherosclerotic disease.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984